Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Editor's Corner


headshot

Appreciating “All Kinds of Minds” in Hematology: Supporting Neurodiverse Colleagues

October 2024

Elna Saah, MD, MS

Dr. Saah explores neurodiversity amongst hematology colleagues including the benefits of a neurodiverse team and the need for better inclusion.

Iron Deficiency Remains Unresolved Years After Diagnosis

October 2024

The majority of patients with iron deficiency did not have resolution of their condition within three years. Among the individuals who did eventually have normal iron stores, resolution of their iron deficiency took almost two years.

Forging a New Standard of Care for Hairy Cell Leukemia

October 2024

ASH Clinical News spoke with experts about the diagnosis and treatment of hairy cell leukemia, including the new chemotherapy-free combination option of vemurafenib plus obinutuzumab for newly diagnosed patients.

Teclistamab Elicits Responses in Patients With Multiple Myeloma Previously Treated With BCMA-Targeted Therapy

October 2024

Treatment with teclistamab in patients with relapsed or refractory multiple myeloma who had been previously treated with an anti-B-cell maturation antigen (BCMA) treatment resulted in statistically significant and clinically meaningful responses to the antibody.

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals